001     136755
005     20240321220129.0
024 7 _ |a 10.1016/j.neuron.2012.09.038
|2 doi
024 7 _ |a pmid:23259946
|2 pmid
024 7 _ |a 0896-6273
|2 ISSN
024 7 _ |a 1097-4199
|2 ISSN
024 7 _ |a altmetric:1137558
|2 altmetric
037 _ _ |a DZNE-2020-03077
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Flynn, Kevin C
|0 P:(DE-2719)2810272
|b 0
|e First author
|u dzne
245 _ _ |a ADF/cofilin-mediated actin retrograde flow directs neurite formation in the developing brain.
260 _ _ |a New York, NY
|c 2012
|b Elsevier
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2012-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710770327_18975
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Neurites are the characteristic structural element of neurons that will initiate brain connectivity and elaborate information. Early in development, neurons are spherical cells but this symmetry is broken through the initial formation of neurites. This fundamental step is thought to rely on actin and microtubule dynamics. However, it is unclear which aspects of the complex actin behavior control neuritogenesis and which molecular mechanisms are involved. Here, we demonstrate that augmented actin retrograde flow and protrusion dynamics facilitate neurite formation. Our data indicate that a single family of actin regulatory proteins, ADF/Cofilin, provides the required control of actin retrograde flow and dynamics to form neurites. In particular, the F-actin severing activity of ADF/Cofilin organizes space for the protrusion and bundling of microtubules, the backbone of neurites. Our data reveal how ADF/Cofilin organizes the cytoskeleton to drive actin retrograde flow and thus break the spherical shape of neurons.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 1
542 _ _ |i 2012-12-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
542 _ _ |i 2013-12-20
|2 Crossref
|u https://www.elsevier.com/open-access/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Actin Depolymerizing Factors
|2 NLM Chemicals
650 _ 7 |a Actins
|2 NLM Chemicals
650 _ 7 |a Destrin
|2 NLM Chemicals
650 _ 7 |a Dstn protein, mouse
|2 NLM Chemicals
650 _ 2 |a Actin Depolymerizing Factors: physiology
|2 MeSH
650 _ 2 |a Actins: metabolism
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Biological Transport
|2 MeSH
650 _ 2 |a Cell Growth Processes: physiology
|2 MeSH
650 _ 2 |a Cell Shape: physiology
|2 MeSH
650 _ 2 |a Cells, Cultured
|2 MeSH
650 _ 2 |a Cerebral Cortex: cytology
|2 MeSH
650 _ 2 |a Cerebral Cortex: embryology
|2 MeSH
650 _ 2 |a Destrin: physiology
|2 MeSH
650 _ 2 |a Growth Cones: metabolism
|2 MeSH
650 _ 2 |a Hippocampus: cytology
|2 MeSH
650 _ 2 |a Hippocampus: embryology
|2 MeSH
650 _ 2 |a In Vitro Techniques
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a Microtubules: physiology
|2 MeSH
650 _ 2 |a Neurites: metabolism
|2 MeSH
650 _ 2 |a Neurogenesis: physiology
|2 MeSH
700 1 _ |a Hellal, Farida
|0 P:(DE-2719)2810276
|b 1
|u dzne
700 1 _ |a Neukirchen, Dorothee
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Jacob, Sonja
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Tahirovic, Sabina
|0 P:(DE-2719)2442036
|b 4
|u dzne
700 1 _ |a Dupraz, Sebastian
|0 P:(DE-2719)2810386
|b 5
|u dzne
700 1 _ |a Stern, Sina
|0 P:(DE-2719)2810277
|b 6
|u dzne
700 1 _ |a Garvalov, Boyan K
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Gurniak, Christine
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Shaw, Alisa E
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Meyn, Liane
|0 P:(DE-2719)2810287
|b 10
|u dzne
700 1 _ |a Wedlich-Söldner, Roland
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Bamburg, James R
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Small, J Victor
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Witke, Walter
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Bradke, Frank
|0 P:(DE-2719)2810270
|b 15
|e Last author
|u dzne
773 1 8 |a 10.1016/j.neuron.2012.09.038
|b : Elsevier BV, 2012-12-01
|n 6
|p 1091-1107
|3 journal-article
|2 Crossref
|t Neuron
|v 76
|y 2012
|x 0896-6273
773 _ _ |a 10.1016/j.neuron.2012.09.038
|g Vol. 76, no. 6, p. 1091 - 1107
|0 PERI:(DE-600)2001944-0
|n 6
|q 76:6<1091 - 1107
|p 1091-1107
|t Neuron
|v 76
|y 2012
|x 0896-6273
856 4 _ |u https://www.sciencedirect.com/science/article/pii/S0896627312008975
856 4 _ |u https://pub.dzne.de/record/136755/files/DZNE-2020-03077_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/136755/files/DZNE-2020-03077_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:136755
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810272
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810276
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2442036
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810386
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810277
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810287
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2810270
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 1
914 1 _ |y 2012
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURON : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NEURON : 2017
920 1 _ |0 I:(DE-2719)1013002
|k AG Bradke
|l Axon Growth and Regeneration
|x 0
920 1 _ |0 I:(DE-2719)1140003
|k AG Tahirovic
|l Juvenile Neurodegeneration
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013002
980 _ _ |a I:(DE-2719)1140003
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21